Delivery Order SPE2DB20D2002-SPE2DB23FL68Y
Award Date
9/11/23
Potential Completion Date
9/12/23
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,459.32 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Medroxyprogesterone 150 mg/mL. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,567.50, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 3, 2024, with a completion date of September 4, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a variety of medical products. The $13,905.91 delivery order covers the supply of Medroxyprogesterone 150 mg/mL, a generic pharmaceutical product, with a completion date of September 8, 2021. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Medroxyprogesterone 150 mg/ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 14, 2021, with a ceiling value of $7,340.28 and a completion date of September 15, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that is registered in the System for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,659.02, is for the delivery of Medroxyprogesterone 150 mg/mL, a pharmaceutical product. The contract has a delivery order type and firm fixed price pricing structure, with a performance period ending on May 22, 2023. The contract is not designated as a set-aside and was awarded through full and...
This federal contract award is for the delivery of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award has a ceiling value of $1,742.40 and is a Firm Fixed Price Delivery Order contract. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. There is no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560784607 units of Medroxyprogesterone 150 mg/ml, a pharmaceutical product, with a total ceiling value of $1,864.81 and a completion date of May 2, 2023. The contract is a delivery order with a firm fixed price and was awarded on May 1, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $1,493.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medroxyprogesterone 150 mg/ml, a medical product. The contract has an ultimate completion date of March 20, 2025 and is a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,567.09 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,565,081,375 milliliters of Medroxyprogesterone 150 mg/ml. This Firm Fixed Price contract has a completion date of July 8, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award, SPE2DX15D3018|SPE2DX23F0AWY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,886.33 firm fixed-price delivery order is for the supply of Medroxyprogesterone 150 mg/ml, a medication used in various medical treatments. The award is not designated under any set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a...